Pilar Navajas Hernández

4PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 18, 2024
Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease.

Pilar Navajas Hernández, Samer Mouhtar El Halabi, Ana Caridad González Parra

|Jun 14, 2023
The HLA-DQA1*05 genotype does not influence the clinical response to ustekinumab and vedolizumab.

Pilar Navajas Hernández, Pilar Del Pino Bellido, Laura Lorenzo González

|Nov 22, 2022
Perianal Paget's disease.

Pilar Navajas Hernández, Teresa Valdés Delgado, Jesús Machuca Aguado

|Oct 20, 2022
A rare gastrointestinal tumor: primary gastric melanoma.

Pilar Navajas Hernández, Pilar Del Pino Bellido, Reyes Aparcero López

Pageof 1

Frequent Collaborators

2 joint publications

Federico Argüelles Arias

1 joint publications

Ángel Caunedo Álvarez

1 joint publications

Jesús Machuca Aguado

1 joint publications

Teresa Valdés Delgado